Experimental cholesterol pill cuts heart attack risk with 'convenient' once-daily dose
The experimental medication, called Obicetrapib, underwent a Phase 3 clinical trial at Monash University in Australia.
The trial included more than 2,500 people averaging 65 years of age. All had either been diagnosed with heart disease or had genetically high cholesterol, according to a university press release.
All participants were receiving "maximum tolerated doses" of cholesterol-lowering therapy.
One group received Obicetrapib and another group took a placebo, while still maintaining their existing cholesterol drugs.
After 12 weeks, the participants taking the new drug showed a 32.6% reduction in LDL cholesterol and a 33.5% drop in lipoprotein(a) [Lp(a)], the release stated.
The findings were presented last month at the European Atherosclerosis Society Congress in the U.K. and were also published in The New England Journal of Medicine.
"We know that many people at high risk of heart attack or stroke don't get their cholesterol levels low enough, even on the best available treatments," said study lead Professor Stephen Nicholls, director of Monash University's Victorian Heart Institute and Monash Health's Victorian Heart Hospital, in the release.
"We know that many people at high risk of heart attack or stroke don't get their cholesterol levels low enough, even on the best available treatments."
"Obicetrapib offers a promising new option — not only did it lower LDL cholesterol by over 30%, but we also saw a reduction in Lp(a), which is much harder to treat and has been linked to increased heart disease risk."
Low-density lipoprotein (LDL), which is sometimes called "bad cholesterol," is associated with negative health effects when present in high amounts.
LDL can build up in the blood vessels and increase heart attack and stroke risk, the researchers cautioned.
Lipoprotein(a), or Lp(a), is a protein that is known to greatly increase the chances of a heart attack when it's present in high levels in the blood.
Unlike LDL, Lp(a) is an inherited risk factor that can't be modified with healthy behaviors or medications.
Obicetrapib was found to be "well-tolerated" by the participants, the researchers noted.
"This could be a valuable tool in the fight against heart disease," Nicholls added. "It's convenient, it's effective, and it may help close the gap for patients who've run out of options."
The study — which was funded by NewAmsterdam Pharma, a developer of Obicetrapib that is based in the Netherlands — did have some limitations, the researchers noted.
For example, the participants were not chosen based on high Lp(a), which means the study did not determine how the drug impacted those with elevated levels of the protein.
Additionally, the study assessed changes in LDL levels, but did not measure actual heart attack or stroke outcomes.
For more Health articles, visit www.foxnews.com/health
More studies are needed to follow patients for longer time periods and to include more diverse cohorts, the researchers acknowledged.
Fox News Digital reached out to the researchers for additional comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
5 hours ago
- Yahoo
Pregnant Woman, 29, Thought She Had Morning Sickness. Then, She Was Diagnosed with a Fast-Growing Cancer
"I went from looking at prams and cots to looking at wigs," the woman told SWNS NEED TO KNOW A pregnant woman who thought she had morning sickness was eventually diagnosed with a fast-growing cancer Sophia Yasin, 29, of Middlesbrough, England, said she was experiencing intense nausea, night sweats and itchiness before her diagnosis She said people around her assured her that her symptoms were 'normal' and would subside with time A pregnant woman thought her extreme nausea was simply morning sickness — until she received a life-altering cancer diagnosis. Sophia Yasin, 29, of Middlesbrough, England, became pregnant in June 2024. The housing support worker and her husband had just purchased a home, and they were looking forward to the future ahead, per SWNS. It was around that time when Sophia began experiencing a host of unpleasant symptoms. "I was [vomiting] all day, every few hours. I was getting night sweats and itchiness through the night. I was very uncomfortable,' she told the outlet. Sophia said people around her told her not to worry, reassuring her that this was all 'normal.' "Everyone told me it was very normal in the first trimester and should ease up,' she recalled, adding, 'I did have some worry, but I thought it was normal for my first pregnancy.' However, her situation took a sudden turn when she collapsed at work at the beginning of her second trimester. "I remember seeing black, and I blacked out,' she told SWNS. Sophia was rushed to the local hospital, where doctors initially suspected she had pneumonia. However, scans and a biopsy revealed that she had a tumor over her heart. She was diagnosed with pre-mediastinal large B-cell non-Hodgkin's lymphoma — a type of cancer that affects the lymphatic system — in September 2024. Never miss a story — sign up for to stay up-to-date on the best of what PEOPLE has to offer, from celebrity news to compelling human interest stories. "I remember saying, 'What does this mean for the baby?' I remember being numb,' Sophia said. The doctors told Sophia that the tumor over her heart was growing fast, and that she needed to begin chemotherapy immediately if she had any chance of survival. However, treatment could also harm or lead to the death of her unborn child. Sophia and her husband ultimately made the difficult decision to terminate the pregnancy based on the many medical variables at hand. While Sophia was devastated by the loss of her pregnancy, she also acknowledged that it may have saved her life. 'Because I was pregnant, I was prioritized [within the health care system]. In a way, because I was pregnant, they found the cancer in time," she told SWNS. Sophia said she was forced to fight for her next chapter while also grieving the loss of what could have been. "I was grieving a baby but trying to have treatment,' she recalled. She added, 'I lost a lot in a short period of time. I went from looking at prams and cots to looking at wigs. I lost my hair, my baby and my old life." Sophia officially went into remission in January 2025 after six rounds of chemotherapy — but she said she has not forgotten the baby she lost — a daughter whom she and her husband named Kainaat Pearl. She told the outlet that she would like to try for a child again, but that doctors have advised her to wait two years, as there is an increased risk of the cancer returning within that window. Sophia has since established a GoFundMe for a fundraising walk to benefit Lymphoma Action, a U.K. charity dedicated to lymphoma. 'Last summer, my world changed forever,' Sophia wrote on the fundraising page. 'In the midst of what should have been one of the happiest times of my life, I faced the unimaginable: fighting for my life while having to say goodbye to my baby girl, Kainaat Pearl.' 'Every step we take is for Kainaat, for those still fighting and for those we've lost,' she added. The GoFundMe has raised $1,356 toward a goal of $1,490. Read the original article on People
Yahoo
7 hours ago
- Yahoo
Prince and Princess of Wales set to move into new home in Windsor
The Prince and Princess of Wales are set to move into a new home in Windsor later this year. William and Kate will move into the eight-bedroom Forest Lodge, nestled in leafy Windsor Great Park, with their children George, Charlotte and Louis, according to Britain's PA Media news agency. 'The Wales family will move house later this year,' a Kensington Palace spokesperson confirmed to CNN on Sunday. The family's current main home at Adelaide Cottage in Windsor is just a stone's throw away from the new property. Earlier this month, permission was granted for minor internal and external alterations at the property, PA reported, citing redacted planning applications lodged with the Royal Borough of Windsor and Maidenhead. The local council's decision notice makes reference to the removal of a window and works to a fireplace, PA said, adding that the park lodge underwent £1.5 million (around $2 million) restoration works in 2001. Photographs taken inside the home at the time showcase the property's original stonework, elaborate plaster cornices and ceiling decoration, according to PA. It is not the first time the family has settled into a new home. In August 2022, it was announced that the couple – then titled the Duke and Duchess of Cambridge – were set to move their family out of London during school term time, in a bid to give their children a 'normal' family life, a royal source told CNN. The latest move follows a turbulent period for the family, after Kate revealed her cancer diagnosis and that she had started chemotherapy last March. As she underwent treatment, she stepped back from public life and only made a few appearances last summer. In September, she announced she had completed chemotherapy and was 'doing what I can to stay cancer free.'
Yahoo
8 hours ago
- Yahoo
Met urged to scrap Carnival facial recognition plan
Civil liberty and anti-racism groups have called on the Metropolitan Police to drop plans to use live facial recognition (LFR) technology at this year's Notting Hill Carnival. In a letter to Met Commissioner Sir Mark Rowley, 11 organisations described LFR as "a mass surveillance tool that treats all Carnival-goers as potential suspects and has no place at one of London's biggest cultural celebrations". They said the decision to reintroduce the technology at Carnival was "deeply disappointing" and argued it could be "less accurate for women and people of colour". The Met Police says LFR is accurate and balanced across ethnicity and gender, and insists it will help keep people safe. The groups - which include Liberty, Big Brother Watch and the Runnymede Trust - highlighted an ongoing judicial review brought by Shaun Thompson, a black Londoner who says he was wrongly identified by the system and detained. The letter states: "There is no clear legal basis for your force's use of LFR. No law mentions facial recognition technology and Parliament has never considered or scrutinised its use. "Notting Hill Carnival is an event that specifically celebrates the British African Caribbean community, yet the [Metropolitan Police] is choosing to use a technology with a well-documented history of inaccurate outcomes and racial bias." The letter also raised concerns over a 2023 National Physical Laboratory study, which found the NeoFace system used by the Met was less accurate for women and people of colour depending on the algorithm that has been set. The study's authors found the system could show bias at lower thresholds, though at the higher settings the Met says it uses, performance was found to be equitable across ethnicity and gender. These thresholds are confidence levels the system uses to decide a match - lower ones flag more people but risk more mistakes and bias, while higher ones are stricter and more balanced. Campaigners said there was no legal obligation for the force to avoid the lower thresholds, and argued policing resources would be better spent on safety measures at the carnival. Deputy Assistant Commissioner Matt Ward, who is leading this year's policing operation at the carnival, said LFR had led to more than 1,000 arrests since the start of 2024 and that independent testing showed the system was "accurate and balanced with regard to ethnicity and gender" at the thresholds used by the Met. Notting Hill Carnival takes place next weekend and has previously attracted up to two million people. It has come under increased scrutiny after two people were murdered at last year's event. Facial recognition tech for Notting Hill Carnival 'Cancelling Carnival won't stop knife crime' 'City Hall should run Notting Hill Carnival' Mr Ward said the force had received the letter and would respond in due course. "Carnival's growing popularity and size creates unique challenges. Around 7,000 officers and staff will be deployed each day," he said. "Their priority is to keep people safe, including preventing serious violence, such as knife crime and violence against women and girls. "It is right that we make the best use of available technology to support officers to do their job more effectively." Mr Ward said the LFR cameras will be used on the approach to and from Carnival and not within the event boundaries. He said they will "help officers identify and intercept those who pose a public safety risk before they get to the crowded streets". BBC News has contacted the carnival's organisers for comment. Listen to the best of BBC Radio London on Sounds and follow BBC London on Facebook, X and Instagram. Send your story ideas to Related internet links Liberty Human Rights Metropolitan Police
